Atlas Trials

A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours.

Clinical trial NCT01285817 · COMPLETED

Trial details

NCT number
NCT01285817
Sponsor
Assistance Publique Hopitaux De Marseille
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Survival Without Progression
Start date
2011-01-12
Primary completion
2015-09-11
Enrollment
79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.